• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗在慢性完全闭塞患者中优于单纯最佳药物治疗:一项荟萃分析。

Percutaneous coronary intervention provided better long term results than optimal medical therapy alone in patients with chronic total occlusion: A meta-analysis.

机构信息

New Cross Hospital, Royal Wolverhampton NHS Trust, UK.

Department of Cardiology, Super-Speciality Hospital, NSCB Medical College, Jabalpur, MP, India.

出版信息

Indian Heart J. 2020 Jul-Aug;72(4):225-231. doi: 10.1016/j.ihj.2020.07.013. Epub 2020 Jul 24.

DOI:10.1016/j.ihj.2020.07.013
PMID:32861374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7474112/
Abstract

AIMS

Studies comparing the outcome of percutaneous coronary intervention (PCI) along with optimal medical therapy (OMT) versus OMT alone in treatment of chronic total occlusion (CTO) are limited by observational design, variable follow-up period, diverse clinical outcomes, high drop-out and cross-over rates. This study aims to conduct a meta-analysis of published data of observational as well as randomized studies comparing long term outcomes of PCI+OMT versus OMT alone.

METHODS AND RESULTS

PubMed, Embase and Cochrane databases were systematically reviewed. 15 studies meeting criteria were included in the meta-analysis. The New-castle Ottawa scale was used to appraise the overall quality of the studies. Random-effects model with inverse variance method was undertaken. Major adverse cardiovascular events (MACE) which comprises of cardiac death, myocardial infarction, stroke, and un-planned revascularization were significantly lower in the PCI+OMT group (RR:0.76; 95% CI:0.61 to 0.95; P=<0.00001; I = 85%). All-cause mortality and cardiac death were significantly lower in the PCI+OMT group (P=<0.00001 in both). Myocardial infarction and stroke rates were lower in the PCI+OMT group, however they did not reach statistical significance (P = 0.24, P = 0.15 respectively). Unplanned revascularizations (of any vessel) were also similar in both the groups (P = 0.78, I = 88%).

CONCLUSION

PCI of CTO is rewarded with better long term outcome, in terms of MACE, all-cause mortality and cardiac death with similar rates of un-planned revascularization.

摘要

目的

比较经皮冠状动脉介入治疗(PCI)联合最佳药物治疗(OMT)与单独 OMT 治疗慢性完全闭塞(CTO)的疗效的研究受到观察性设计、随访时间不同、临床结局多样化、高脱落率和交叉率的限制。本研究旨在对比较 PCI+OMT 与单独 OMT 的长期疗效的观察性和随机研究的已发表数据进行荟萃分析。

方法和结果

系统检索了 PubMed、Embase 和 Cochrane 数据库。纳入了符合标准的 15 项研究进行荟萃分析。采用纽卡斯尔-渥太华量表评估研究的总体质量。采用逆方差法进行随机效应模型分析。主要心血管不良事件(MACE)包括心脏死亡、心肌梗死、卒中和非计划性血运重建,PCI+OMT 组显著降低(RR:0.76;95%CI:0.61 至 0.95;P<0.00001;I=85%)。PCI+OMT 组全因死亡率和心脏死亡率也显著降低(均 P<0.00001)。PCI+OMT 组心肌梗死和卒中等发生率较低,但无统计学意义(P=0.24,P=0.15)。两组非计划性血运重建(任何血管)也相似(P=0.78,I=88%)。

结论

CTO 的 PCI 可带来更好的长期疗效,在 MACE、全因死亡率和心脏死亡率方面有获益,且非计划性血运重建的发生率相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea93/7474112/db8f8776b175/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea93/7474112/a6ea051e29bd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea93/7474112/db8f8776b175/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea93/7474112/a6ea051e29bd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea93/7474112/db8f8776b175/gr2.jpg

相似文献

1
Percutaneous coronary intervention provided better long term results than optimal medical therapy alone in patients with chronic total occlusion: A meta-analysis.经皮冠状动脉介入治疗在慢性完全闭塞患者中优于单纯最佳药物治疗:一项荟萃分析。
Indian Heart J. 2020 Jul-Aug;72(4):225-231. doi: 10.1016/j.ihj.2020.07.013. Epub 2020 Jul 24.
2
Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10-Year Follow-Up Study.经皮冠状动脉介入治疗与药物治疗对冠状动脉慢性完全闭塞患者生存获益的比较:一项 10 年随访研究。
J Am Heart Assoc. 2021 Mar 16;10(6):e019022. doi: 10.1161/JAHA.120.019022. Epub 2021 Mar 4.
3
Percutaneous Coronary Intervention Versus Medical Therapy for Chronic Total Occlusion of Coronary Arteries: A Systematic Review and Meta-Analysis.经皮冠状动脉介入治疗与药物治疗慢性冠状动脉完全闭塞的比较:系统评价和荟萃分析。
Curr Atheroscler Rep. 2019 Aug 9;21(10):42. doi: 10.1007/s11883-019-0804-8.
4
Optimal medical therapy vs. coronary revascularization for patients presenting with chronic total occlusion: A meta-analysis of randomized controlled trials and propensity score adjusted studies.慢性完全闭塞患者的最佳药物治疗与冠状动脉血运重建:随机对照试验和倾向评分调整研究的荟萃分析
Catheter Cardiovasc Interv. 2019 May 1;93(6):E320-E325. doi: 10.1002/ccd.28037. Epub 2018 Dec 13.
5
Percutaneous Coronary Intervention With Drug-Eluting Stent Versus Optimal Medical Therapy for Chronic Total Occlusion: Systematic Review and Meta-Analysis.经皮冠状动脉介入治疗联合药物洗脱支架与最佳药物治疗用于慢性完全闭塞病变的系统评价和荟萃分析。
Angiology. 2019 Nov;70(10):908-915. doi: 10.1177/0003319719858823. Epub 2019 Jun 30.
6
Optimal medical therapy may be a better initial strategy in patients with chronic total occlusion of a single coronary artery.对于单支冠状动脉慢性完全闭塞的患者,优化药物治疗可能是更好的初始策略。
Int J Cardiol. 2016 May 1;210:56-62. doi: 10.1016/j.ijcard.2016.02.084. Epub 2016 Feb 16.
7
Long-term follow-up of patients with chronic total coronary artery occlusion previously randomized to treatment with optimal drug therapy or percutaneous revascularization of chronic total occlusion (COMET-CTO).慢性冠状动脉完全闭塞患者的长期随访,这些患者先前被随机分配接受最佳药物治疗或慢性完全闭塞病变的经皮血管重建治疗(COMET-CTO研究)。
Front Cardiovasc Med. 2023 Jan 9;9:1014664. doi: 10.3389/fcvm.2022.1014664. eCollection 2022.
8
Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO).慢性完全闭塞病变血运重建与最佳药物治疗的随机多中心试验(EuroCTO)3 年结果
EuroIntervention. 2023 Sep 18;19(7):571-579. doi: 10.4244/EIJ-D-23-00312.
9
Long-term clinical outcomes of optimal medical therapy vs. successful percutaneous coronary intervention for patients with coronary chronic total occlusions.慢性冠状动脉完全闭塞患者最佳药物治疗与经皮冠状动脉介入治疗的长期临床结局比较。
Hellenic J Cardiol. 2018 Sep-Oct;59(5):281-287. doi: 10.1016/j.hjc.2018.03.005. Epub 2018 Mar 30.
10
Outcomes of Percutaneous Coronary Intervention Versus Optimal Medical Treatment for Chronic Total Occlusion: A Comprehensive Meta-analysis.经皮冠状动脉介入治疗与最佳药物治疗慢性完全闭塞的结局:一项综合荟萃分析。
Curr Probl Cardiol. 2021 Mar;46(3):100695. doi: 10.1016/j.cpcardiol.2020.100695. Epub 2020 Aug 28.

引用本文的文献

1
Complete vs. incomplete percutaneous revascularization in patients with chronic total coronary artery occlusion.慢性冠状动脉完全闭塞患者的完全性与不完全性经皮血管重建术
Front Cardiovasc Med. 2024 Jul 23;11:1443258. doi: 10.3389/fcvm.2024.1443258. eCollection 2024.
2
Is it the Time to Move Towards Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve Guided Percutaneous Coronary Intervention? The Pros and Cons.是否是时候转向基于冠状动脉计算机断层血管造影的血流储备分数指导的经皮冠状动脉介入治疗?利弊分析。
Curr Cardiol Rev. 2023;19(4):e190123212887. doi: 10.2174/1573403X19666230119115228.
3
Long-Term Predictors of Hospitalized Reinfarction after an Incident Acute Myocardial Infarction.

本文引用的文献

1
Outcomes of Chronic Total Occlusions in Coronary Arteries According to Three Therapeutic Strategies: A Meta-analysis with 6985 Patients from 8 Published Observational Studies.根据三种治疗策略分析冠状动脉慢性完全闭塞的结局:一项对8项已发表观察性研究中6985例患者的荟萃分析
Braz J Cardiovasc Surg. 2019 Dec 1;34(6):645-652. doi: 10.21470/1678-9741-2018-0176.
2
Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion.随机临床试验评估经皮冠状动脉介入治疗慢性完全闭塞。
Circulation. 2019 Apr 2;139(14):1674-1683. doi: 10.1161/CIRCULATIONAHA.118.031313.
3
Optimal medical therapy vs. coronary revascularization for patients presenting with chronic total occlusion: A meta-analysis of randomized controlled trials and propensity score adjusted studies.
首次急性心肌梗死后住院再梗死的长期预测因素
Life (Basel). 2022 Dec 13;12(12):2090. doi: 10.3390/life12122090.
4
Procedural Success Prediction Scoring Systems Used in Percutaneous Coronary Interventions for Chronic Total Occlusions: A Systematic Evaluation.用于慢性完全闭塞病变经皮冠状动脉介入治疗的手术成功预测评分系统:一项系统评价
Healthcare (Basel). 2021 Aug 11;9(8):1033. doi: 10.3390/healthcare9081033.
慢性完全闭塞患者的最佳药物治疗与冠状动脉血运重建:随机对照试验和倾向评分调整研究的荟萃分析
Catheter Cardiovasc Interv. 2019 May 1;93(6):E320-E325. doi: 10.1002/ccd.28037. Epub 2018 Dec 13.
4
Comparison of successful percutaneous coronary intervention versus optimal medical therapy in patients with coronary chronic total occlusion.比较经皮冠状动脉介入治疗与最佳药物治疗在冠状动脉慢性完全闭塞患者中的疗效。
J Cardiol. 2019 Feb;73(2):156-162. doi: 10.1016/j.jjcc.2018.08.006. Epub 2018 Nov 6.
5
Percutaneous coronary intervention versus optimal medical therapy for patients with chronic total occlusion: a meta-analysis and systematic review.经皮冠状动脉介入治疗与最佳药物治疗对慢性完全闭塞患者的疗效比较:一项荟萃分析与系统评价
J Thorac Dis. 2018 May;10(5):2960-2967. doi: 10.21037/jtd.2018.04.140.
6
Revascularization vs. Medical Therapy for Coronary Chronic Total Occlusions in Patients With Chronic Kidney Disease.慢性肾脏病患者冠状动脉慢性完全闭塞血运重建与药物治疗的比较
Circ J. 2018 Jul 25;82(8):2136-2142. doi: 10.1253/circj.CJ-17-1272. Epub 2018 Jun 14.
7
Five-Year Outcomes of Successful Percutaneous Coronary Intervention with Drug-Eluting Stents versus Medical Therapy for Chronic Total Occlusions.药物洗脱支架成功经皮冠状动脉介入治疗与药物治疗慢性完全闭塞病变的五年结局
Yonsei Med J. 2018 Jul;59(5):602-610. doi: 10.3349/ymj.2018.59.5.602.
8
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.一项比较血管再通治疗与最佳药物治疗慢性完全闭塞性冠状动脉病变的随机多中心试验。
Eur Heart J. 2018 Jul 7;39(26):2484-2493. doi: 10.1093/eurheartj/ehy220.
9
Long-term clinical outcomes of optimal medical therapy vs. successful percutaneous coronary intervention for patients with coronary chronic total occlusions.慢性冠状动脉完全闭塞患者最佳药物治疗与经皮冠状动脉介入治疗的长期临床结局比较。
Hellenic J Cardiol. 2018 Sep-Oct;59(5):281-287. doi: 10.1016/j.hjc.2018.03.005. Epub 2018 Mar 30.
10
Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Chronic Total Coronary Occlusion With Well-Developed Collaterals.慢性完全闭塞病变伴侧支循环良好患者行经皮冠状动脉介入治疗与最佳药物治疗的比较。
J Am Heart Assoc. 2017 Sep 13;6(9):e006357. doi: 10.1161/JAHA.117.006357.